BPHL Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q86WA6 |
---|---|
Clone Names | 100324276 |
Gene ID | 670 |
---|---|
Other Names | Valacyclovir hydrolase, VACVase, Valacyclovirase, 31--, Biphenyl hydrolase-like protein, Biphenyl hydrolase-related protein, Bph-rp, Breast epithelial mucin-associated antigen, MCNAA, BPHL, MCNAA |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BPHL |
---|---|
Synonyms | MCNAA |
Function | Serine hydrolase that catalyzes the hydrolytic activation of amino acid ester prodrugs of nucleoside analogs such as valacyclovir and valganciclovir. Activates valacyclovir to acyclovir. May play a role in detoxification processes. It is a specific alpha-amino acid ester hydrolase that prefers small, hydrophobic, and aromatic side chains and does not have a stringent requirement for the leaving group other than preferring a primary alcohol. |
Tissue Location | Expressed at high levels in liver and kidney and lower levels in heart, intestine and skeletal muscle |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a member of the serine protease familyof hydrolytic enzymes which contain a serine in their active site.The encoded protein may play a role in activation of the antiviralprodrug valacyclovir. Alternatively spliced transcript variantshave been described.
References
Davila, S., et al. Genes Immun. 11(3):232-238(2010)Lai, L., et al. J. Biol. Chem. 283(14):9318-9327(2008)Grigo, K., et al. Biol. Chem. 389(2):179-187(2008)Melk, A., et al. Kidney Int. 68(6):2667-2679(2005)Kim, I., et al. Mol. Pharm. 1(6):434-446(2004)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.